This report aims to provide a comprehensive presentation of the global market for Hospital-acquired infections (HAIs) Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-acquired infections (HAIs) Control. This report contains market size and forecasts of Hospital-acquired infections (HAIs) Control in global, including the following market information:
Global Hospital-acquired infections (HAIs) Control Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Hospital-acquired infections (HAIs) Control market was valued at US$ 5867.2 million in 2022 and is projected to reach US$ 7101.9 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnostic techniques Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hospital-acquired infections (HAIs) Control include STERIS Corporation, Advanced Sterilization Products Division, Hoffmann-La Roche, Pfizer and Becton Dickinson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Hospital-acquired infections (HAIs) Control companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-acquired infections (HAIs) Control Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Hospital-acquired infections (HAIs) Control Market Segment Percentages, by Type, 2022 (%)
Diagnostic techniques
Dleaning and sterilization
Treatment
Global Hospital-acquired infections (HAIs) Control Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Hospital-acquired infections (HAIs) Control Market Segment Percentages, by Application, 2022 (%)
General Hospital
Infectious Disease Hospital
Global Hospital-acquired infections (HAIs) Control Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Hospital-acquired infections (HAIs) Control Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital-acquired infections (HAIs) Control revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital-acquired infections (HAIs) Control revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
STERIS Corporation
Advanced Sterilization Products Division
Hoffmann-La Roche
Pfizer
Becton Dickinson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital-acquired infections (HAIs) Control, market overview.
Chapter 2: Global Hospital-acquired infections (HAIs) Control market size in revenue.
Chapter 3: Detailed analysis of Hospital-acquired infections (HAIs) Control company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital-acquired infections (HAIs) Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital-acquired infections (HAIs) Control Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-acquired infections (HAIs) Control Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-acquired infections (HAIs) Control Overall Market Size
2.1 Global Hospital-acquired infections (HAIs) Control Market Size: 2022 VS 2032
2.2 Global Hospital-acquired infections (HAIs) Control Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-acquired infections (HAIs) Control Players in Global Market
3.2 Top Global Hospital-acquired infections (HAIs) Control Companies Ranked by Revenue
3.3 Global Hospital-acquired infections (HAIs) Control Revenue by Companies
3.4 Top 3 and Top 5 Hospital-acquired infections (HAIs) Control Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital-acquired infections (HAIs) Control Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-acquired infections (HAIs) Control Players in Global Market
3.6.1 List of Global Tier 1 Hospital-acquired infections (HAIs) Control Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-acquired infections (HAIs) Control Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-acquired infections (HAIs) Control Market Size Markets, 2022 & 2032
4.1.2 Diagnostic techniques
4.1.3 Dleaning and sterilization
4.1.4 Treatment
4.2 By Type - Global Hospital-acquired infections (HAIs) Control Revenue & Forecasts
4.2.1 By Type - Global Hospital-acquired infections (HAIs) Control Revenue, 2018-2023
4.2.2 By Type - Global Hospital-acquired infections (HAIs) Control Revenue, 2024-2032
4.2.3 By Type - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-acquired infections (HAIs) Control Market Size, 2022 & 2032
5.1.2 General Hospital
5.1.3 Infectious Disease Hospital
5.2 By Application - Global Hospital-acquired infections (HAIs) Control Revenue & Forecasts
5.2.1 By Application - Global Hospital-acquired infections (HAIs) Control Revenue, 2018-2023
5.2.2 By Application - Global Hospital-acquired infections (HAIs) Control Revenue, 2024-2032
5.2.3 By Application - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Hospital-acquired infections (HAIs) Control Market Size, 2022 & 2032
6.2 By Region - Global Hospital-acquired infections (HAIs) Control Revenue & Forecasts
6.2.1 By Region - Global Hospital-acquired infections (HAIs) Control Revenue, 2018-2023
6.2.2 By Region - Global Hospital-acquired infections (HAIs) Control Revenue, 2024-2032
6.2.3 By Region - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Hospital-acquired infections (HAIs) Control Revenue, 2018-2032
6.3.2 US Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.3.3 Canada Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.3.4 Mexico Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Hospital-acquired infections (HAIs) Control Revenue, 2018-2032
6.4.2 Germany Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4.3 France Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4.4 U.K. Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4.5 Italy Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4.6 Russia Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4.7 Nordic Countries Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.4.8 Benelux Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Hospital-acquired infections (HAIs) Control Revenue, 2018-2032
6.5.2 China Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.5.3 Japan Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.5.4 South Korea Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.5.5 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.5.6 India Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Hospital-acquired infections (HAIs) Control Revenue, 2018-2032
6.6.2 Brazil Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.6.3 Argentina Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue, 2018-2032
6.7.2 Turkey Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.7.3 Israel Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.7.4 Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
6.7.5 UAE Hospital-acquired infections (HAIs) Control Market Size, 2018-2032
7 Hospital-acquired infections (HAIs) Control Companies Profiles
7.1 STERIS Corporation
7.1.1 STERIS Corporation Company Summary
7.1.2 STERIS Corporation Business Overview
7.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Major Product Offerings
7.1.4 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue in Global Market (2018-2023)
7.1.5 STERIS Corporation Key News & Latest Developments
7.2 Advanced Sterilization Products Division
7.2.1 Advanced Sterilization Products Division Company Summary
7.2.2 Advanced Sterilization Products Division Business Overview
7.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Major Product Offerings
7.2.4 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue in Global Market (2018-2023)
7.2.5 Advanced Sterilization Products Division Key News & Latest Developments
7.3 Hoffmann-La Roche
7.3.1 Hoffmann-La Roche Company Summary
7.3.2 Hoffmann-La Roche Business Overview
7.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Major Product Offerings
7.3.4 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue in Global Market (2018-2023)
7.3.5 Hoffmann-La Roche Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Hospital-acquired infections (HAIs) Control Major Product Offerings
7.4.4 Pfizer Hospital-acquired infections (HAIs) Control Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Becton Dickinson
7.5.1 Becton Dickinson Company Summary
7.5.2 Becton Dickinson Business Overview
7.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Major Product Offerings
7.5.4 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue in Global Market (2018-2023)
7.5.5 Becton Dickinson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital-acquired infections (HAIs) Control Market Opportunities & Trends in Global Market
Table 2. Hospital-acquired infections (HAIs) Control Market Drivers in Global Market
Table 3. Hospital-acquired infections (HAIs) Control Market Restraints in Global Market
Table 4. Key Players of Hospital-acquired infections (HAIs) Control in Global Market
Table 5. Top Hospital-acquired infections (HAIs) Control Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital-acquired infections (HAIs) Control Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital-acquired infections (HAIs) Control Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital-acquired infections (HAIs) Control Product Type
Table 9. List of Global Tier 1 Hospital-acquired infections (HAIs) Control Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-acquired infections (HAIs) Control Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2024-2032
Table 30. STERIS Corporation Company Summary
Table 31. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offerings
Table 32. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (US$, Mn) & (2018-2023)
Table 33. STERIS Corporation Key News & Latest Developments
Table 34. Advanced Sterilization Products Division Company Summary
Table 35. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offerings
Table 36. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (US$, Mn) & (2018-2023)
Table 37. Advanced Sterilization Products Division Key News & Latest Developments
Table 38. Hoffmann-La Roche Company Summary
Table 39. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offerings
Table 40. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (US$, Mn) & (2018-2023)
Table 41. Hoffmann-La Roche Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Hospital-acquired infections (HAIs) Control Product Offerings
Table 44. Pfizer Hospital-acquired infections (HAIs) Control Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Becton Dickinson Company Summary
Table 47. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offerings
Table 48. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (US$, Mn) & (2018-2023)
Table 49. Becton Dickinson Key News & Latest Developments
List of Figures
Figure 1. Hospital-acquired infections (HAIs) Control Segment by Type in 2022
Figure 2. Hospital-acquired infections (HAIs) Control Segment by Application in 2022
Figure 3. Global Hospital-acquired infections (HAIs) Control Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Hospital-acquired infections (HAIs) Control Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-acquired infections (HAIs) Control Revenue in 2022
Figure 8. By Type - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 9. By Application - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 10. By Type - Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 12. By Application - Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 14. By Region - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 15. By Country - North America Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 16. US Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 20. Germany Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 21. France Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 28. China Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 32. India Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 34. Brazil Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue Market Share, 2018-2032
Figure 37. Turkey Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2018-2032
Figure 41. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
